chr10-30341649-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_018109.4(MTPAP):c.158-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000915 in 1,613,574 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0046 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 6 hom. )
Consequence
MTPAP
NM_018109.4 intron
NM_018109.4 intron
Scores
2
Splicing: ADA: 0.00002277
2
Clinical Significance
Conservation
PhyloP100: 1.34
Genes affected
MTPAP (HGNC:25532): (mitochondrial poly(A) polymerase) The protein encoded by this gene is a member of the DNA polymerase type-B-like family. This enzyme synthesizes the 3' poly(A) tail of mitochondrial transcripts and plays a role in replication-dependent histone mRNA degradation.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 10-30341649-G-A is Benign according to our data. Variant chr10-30341649-G-A is described in ClinVar as [Benign]. Clinvar id is 378178.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-30341649-G-A is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTPAP | NM_018109.4 | c.158-9C>T | intron_variant | ENST00000263063.9 | NP_060579.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTPAP | ENST00000263063.9 | c.158-9C>T | intron_variant | 1 | NM_018109.4 | ENSP00000263063.3 | ||||
MTPAP | ENST00000417581.1 | c.-38-9C>T | intron_variant | 5 | ENSP00000404392.1 | |||||
MTPAP | ENST00000421701.1 | c.44-9C>T | intron_variant | 2 | ENSP00000394118.1 | |||||
MTPAP | ENST00000488290.5 | n.1913-9C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00462 AC: 703AN: 152124Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
703
AN:
152124
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00141 AC: 355AN: 250892Hom.: 3 AF XY: 0.00118 AC XY: 160AN XY: 135646
GnomAD3 exomes
AF:
AC:
355
AN:
250892
Hom.:
AF XY:
AC XY:
160
AN XY:
135646
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000528 AC: 772AN: 1461332Hom.: 6 Cov.: 31 AF XY: 0.000506 AC XY: 368AN XY: 726984
GnomAD4 exome
AF:
AC:
772
AN:
1461332
Hom.:
Cov.:
31
AF XY:
AC XY:
368
AN XY:
726984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00462 AC: 704AN: 152242Hom.: 1 Cov.: 32 AF XY: 0.00458 AC XY: 341AN XY: 74434
GnomAD4 genome
AF:
AC:
704
AN:
152242
Hom.:
Cov.:
32
AF XY:
AC XY:
341
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 09, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Sep 18, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at